Latin American Update: Targeting Accessible and Affordable Essential Drugs. Essential Drugs Monitor No. 013 (1992)
(1992; 2 pages)


In March 1992, 50 senior policymakers from 15 Latin American countries met in Caracas, Venezuela for a three-day conference aimed at identifying regional problems, exchanging experiences on the drug market, and studying the economic and public health benefits of the essential drugs concept. In light of the conference and this regional movement, the Essential Drugs Monitor highlighted various national initiatives throughout Latin America. Colombia introduced a new national drug policy and is conducting a publicity campaign to promote it. The main message of the campaign is that essential drugs are the best medications for doctors to prescribe and generic drugs are the best for patients to take. Colombia has also compiled a new national formulary, held seminars to present the new policy, and began a programme of hospital visits aimed at educating health care workers. Public information posts to give consumers information about generic medicines have also been set up at pharmacies. Bolivia began a national essential drugs programme in 1991. The program serves as the cornerstone of the country’s new national policy aimed at rationalizing both public and private health sectors. Bolivia has assigned responsibilities to both national and regional levels, made efforts to train administrative and health professionals in administrative and financial management of drugs, and begun promoting rational use. Guatemala has taken several steps over the last ten years to rationalize drug use and improve drug accessibility. These steps include the formation of a national drugs list, the establishment of a drug control lab, and the establishment of a national drug information center. Guatemala has also created a working system of drug management; since implementing the system, reliable drug sources seem to have been ensured. (Abstract by Flannery Bowman, 2013)

El Portal de Información - Medicamentos Esenciales y Productos de Salud de la OMS fue diseñado y es mantenido por la ONG Human Info. Última actualización: le 1 diciembre 2019